NBOC increases their holding by 117 per cent“As Theratech's decision to focus primarily on its commercial assets is less risky (vs. early-stage oncology clinical trials) and, likely, to yield results in the NTM, NBF considers this update to be positive. However, given expectations of a generally challenging operating/economic environment (i.e., inflation, labor scarcity, potential supply chain disruptions, etc.) the return to profitability will be monitored closely.
Maintain Sector Perform rating and $3.25 target
National Bank of Canada which owns National Bank Financial increased their holding by 117% as of 2022-12-31 despite the fact that their analyst has been very skeptical of the oncology program from the go and due to “challenging environment” is monitoring the commercial assets’ success…
National Bank Of Canada /fi/ reports 117.30% increase in ownership of TH / Theratechnologies Inc - 13F, 13D, 13G Filings - Fintel.io